Literature DB >> 26877599

Mechanism and Function of Angiogenin in Hematopoietic Malignancy.

Kevin A Goncalves1, Guo-Fu Hu1.   

Abstract

Angiogenic factors have been widely implicated in the formation and progression of solid tumors. A number of angiogenic mediators have been recently appreciated as having equivalent function in non-solid tumors, such as leukemia. One such factor, angiogenin (ANG), promotes tumor cell growth and angiogenesis in solid cancers; however its precise function(s) in hematological disorders are not fully understood. This review summarizes current knowledge of the function and therapeutic potential of angiogenic factors, with particular emphasis on the role and hypothesized mechanism of ANG in a non-solid tumor setting.

Entities:  

Keywords:  RNA processing; angiogenesis; angiogenin; bone marrow diseases; cancer; cell proliferation; leukemia; malignant hematopoiesis

Year:  2015        PMID: 26877599      PMCID: PMC4750500     

Source DB:  PubMed          Journal:  Zhongguo Sheng Wu Hua Xue Yu Fen Zi Sheng Wu Xue Bao        ISSN: 1007-7626


  109 in total

1.  Platelet-derived growth factor is angiogenic in vivo.

Authors:  W Risau; H Drexler; V Mironov; A Smits; A Siegbahn; K Funa; C H Heldin
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

2.  Elevated expression of angiogenin in prostate cancer and its precursors.

Authors:  Terrence M Katona; Blake Lee Neubauer; Philip W Iversen; Shaobo Zhang; Lee Ann Baldridge; Liang Cheng
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

3.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

4.  Antiangiogenic therapy in myelodysplastic syndromes: is there a role?

Authors:  Stephen T Oh; Jason Gotlib
Journal:  Curr Hematol Malig Rep       Date:  2008-01       Impact factor: 3.952

Review 5.  Angiogenesis in chronic myeloproliferative diseases.

Authors:  F Di Raimondo; G A Palumbo; S Molica; R Giustolisi
Journal:  Acta Haematol       Date:  2001       Impact factor: 2.195

6.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

Review 7.  Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.

Authors:  Asmaa E El-Kenawi; Azza B El-Remessy
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

8.  Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.

Authors:  Michael G Alexandrakis; Freda H Passam; Constantina A Pappa; Katerina Sfiridaki; George Tsirakis; John Damilakis; Efstathios N Stathopoulos; Despina S Kyriakou
Journal:  Leuk Res       Date:  2005-01       Impact factor: 3.156

9.  The widespread expression of angiogenin in different human cells suggests a biological function not only related to angiogenesis.

Authors:  M Moenner; M Gusse; E Hatzi; J Badet
Journal:  Eur J Biochem       Date:  1994-12-01

10.  Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.

Authors:  D Ribatti; A Vacca; B Nico; F Quondamatteo; R Ria; M Minischetti; A Marzullo; R Herken; L Roncali; F Dammacco
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  2 in total

1.  Comparison of Proteome Composition of Serum Enriched in Extracellular Vesicles Isolated from Polycythemia Vera Patients and Healthy Controls.

Authors:  Anna Fel; Aleksandra E Lewandowska; Petro E Petrides; Jacek R Wiśniewski
Journal:  Proteomes       Date:  2019-05-06

Review 2.  Angiogenin (ANG)-Ribonuclease Inhibitor (RNH1) System in Protein Synthesis and Disease.

Authors:  Mayuresh Anant Sarangdhar; Ramanjaneyulu Allam
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.